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Abstract
Background: Helicobacter pylori is a Gram negative bacterium that plays a central role in the
etiology of chronic gastritis and peptic ulcer diseases. However, not all H. pylori positive cases
develop advanced disease. This discriminatory behavior has been attributed to the difference in
virulence of the bacteria. Among all virulence factors, cytotoxin released by H. pylori is the most
important factor. In this work, we studied variation in H. pylori isolates from Indian dyspeptic
patients on the basis of cytotoxin production and associated changes in K+-dependent ATPase (one
of its targets) enzyme activity in HeLa cells.
Methods:  The patients were retrospectively grouped on the basis of endoscopic and
histopathological observation as having gastritis or peptic ulcer. The HeLa cells were incubated
with the broth culture filtrates (BCFs) of H. pylori isolates from patients of both groups and
observed for the cytopathic effects: morphological changes and viability. In addition, the K+-
dependent ATPase activity was measured in HeLa cells extracts.
Results: The cytotoxin production was observed in 3/7 (gastritis) and 4/4 (peptic ulcer) H. pylori
isolates. The BCFs of cytotoxin producing H. pylori strains reduced the ATPase activity of HeLa cells
to 40% of that measured with non-cytotoxin producing H. pylori strains (1.33 µmole Pi/mg protein
and 3.36 µmole Pi/mg protein, respectively, p < 0.05). The decreased activity of ATPase enzyme or
the release of cytotoxin also correlated with the increased pathogenicity indices of the patients.
Conclusions: Our results suggest that the isolation of cytotoxic H. pylori is more common in
severe form of acid peptic diseases (peptic ulcer) than in gastritis patients from India. Also the
cytotoxin released by H. pylori impairs the ion-transporting ATPase and is a measure of cytotoxicity.
Background
Helicobacter pylori is a spiral Gram negative, microaer-
ophilic bacterial parasite that inhabitates gastric epithe-
lium [1]. The long-term H. pylori infection has been found
associated with gastritis, gastric and duodenal ulcer, B-cell
lymphoma and adenocarcinoma of the stomach [2–4]. H.
pylori infection is common in both developed and devel-
oping countries. It is estimated that in developed coun-
tries 30–50% of the adult population is infected. In
developing countries, the prevalence of H. pylori infection
is noted even higher-approximately 80% [5,6]. Interest-
ingly, not all the H. pylori infected individuals develop
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peptic ulcer or gastric cancer. A significant number of
patients have milder form of disease, like inflammation in
stomach and duodenum [7,8]. Such discriminatory
behavior of H. pylori can be linked to the ability or inabil-
ity of the bacteria to express various virulence factors.
These virulence factors help H. pylori in adapting to its
environment and are subject to variation from one geo-
graphical location to another [9–12]. The virulence factors
of H. pylori responsible for its pathogenesis and survival in
harsh acidic environment include spiral morphology,
motility, lipases, protease and urease enzymes, and cyto-
toxin production [9–12].
The expression of cytotoxin-associated gene (cagA and/or
vacA) and cytotoxin production by H. pylori strains has
been studied and correlated with their enhanced patho-
genic potential [13–15]. But no explicit cause-effect rela-
tionship has been demonstrated between the cytotoxin
and the clinical outcome in the patients. Secondly,
depending on the geographical area, the genotypic and
phenotypic differences among H. pylori strains exclude
generalization of studies done in developed countries.
These differences arise, among other factors, from eating
habits, economic status and prevailing hygienic condi-
tions [16–18]. In our previous study, we investigated the
association between the differences in zymograms of H.
pylori isolates and clinical presentation of the disease in
Indian dyspeptic patients [19]. Over 40% of the H. pylori
isolates were found belonging to a biotype that expressed
alkaline phosphatase, esterase-lipase, naphthol-AS-beta-
1-phosphohydrolase, esterase and acid phosphatase [19].
However, no correlation was found between the biotype
and disease status of the patients. Other investigators also
failed to find any association between the cytotoxin gene/
antigen in H. pylori isolates from Indian patients with the
clinical outcome [20,21]. To further investigate the strain-
differences among H. pylori, in the present study, the iso-
lates were studied for cytotoxin production and the
changes in ATPase activity of target (HeLa) cells. Since
amino terminal sequence of this toxin shows partial
homogeneity with the sequences of ion-transporting
ATPase, it has been suggested that ATPase may be the one
of the targets of cytotoxin produced by H. pylori [13].
In the present study, we found that the cytotoxic H. pylori
were isolated commonly from peptic ulcer patients. And
only half of H. pylori isolates from, gastritis, the milder
form than ulcer, were cytotoxic. In addition, the cytotoxic
H. pylori strains decrease the ATPase activity of HeLa cells,
which correlates with the severe damage and increased
pathogenicity indices of the patients.
Methods
Patients and disease status
A total of 11 isolates of H. pylori, isolated from antral biop-
sies of patients with gastritis (Group I, n = 7) and peptic
ulcer (Group II, n = 4) were included in the present study.
These patients (male 9, female 2) ranged in age from 10–
38 years (mean 30.2 years) and none of the patients
received any antimicrobial therapy for at least four weeks
prior to the study. The patients showed typical clinical
symptoms of peptic ulcer diseases: dyspepsia, heartburn
and epigastric pain. They underwent gastroduodenoscopy
for both visual examination and biopsy collection. The
disease status of the patients was defined on the basis of
endoscopic and/or histopathological positivity for
inflammation.
At least four antral gastric biopsies were obtained from
each patient using gastrovideoendoscope (Olympus,
Japan) for histopathology, rapid urease test, modified
Gram's staining and culture of H. pylori. For histopathol-
ogy, the biopsy was collected in 10% formalin buffered-
saline. Tissue sample was dehyrated, infiltrated, embed-
ded in paraffin wax, sectioned and stained with Haema-
toxylin and Eosin and Giemsa stain. The slides were then
examined for histopathological changes [19]. In addition
the biopsies were examined for H. pylori by rapid urease
test and microscopic examination of impression and
crushed smear after staining with modified Gram's stain
as per the method described earlier [19].
Reference cytotoxin producing strain, H. pylori CCUG
17874 was obtained from Culture Collection University
of Goteborg, Goteborg, Sweden.
Electron Microscopy
Transmission electron microscopy of the biopsies was per-
formed as described earlier [22,23]. Briefly, the biopsies
were fixed in 3% glutaraldehyde-2% paraformaldehyde
solution (3 h) followed by fixing in 1% osmium teraoxide
(4°C for 1 h) in 0.1 M cacodylate buffer. The samples were
dehydrated in diluted aqueous acetone, infiltrated and
embedded in plastic mixture. Finally, the samples were
trimmed into ultrathin sections (1 µm) using Ultratome
8800 (LKB, USA). The sections were stained with uranyl
acetate and lead citrate solutions before examining under
transmission electron microscope (Phillips EM 416LS,
Holland) at an accelerating voltage of 80 KV. Few repre-
sentative areas were photographed on orthochromatic
electron microscopic sheet films (Kodak, UK) under dif-
ferent magnifications. For scanning electron microscopy
of H. pylori, the bacteria were fixed using 0.1% poly-L-
lysine and dehydrated in ethanol and ethanol: isoamyl
acetate solution. The samples were dried in Balzer's union
critical point dryer by gradual replacement of isoamyl ace-
tate with liquid CO2. The dried samples were mounted onBMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/31
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aluminium stubs, coated with Au-Pd alloy (160 Å) and
scanned (Scanning electron microscope, Phillips 515,
Holland) at varying magnifications [24].
Isolation of H. pylori and preparation of broth culture 
filtrates (BCFs)
The endoscopic biopsies were cultured on Columbia
Chocolate agar plates (Difco, USA) containing 7% defibri-
nated sheep blood and antibiotics (6 mg/ml vancomycin,
1000 U/ml polymyxin B and 2 mg/ml amphotericin B;
Sigma, USA) to inhibit the growth of commensals. Bacte-
rial colonies were grown under microaerobic condition at
37°C for 48–72 h. Finally, translucent H. pylori colonies
were identified on the basis of spiral morphology and
presence of oxidase, catalase and urease enzyme activity as
per the method described earlier [19].
The H. pylori isolates thus cultured were grown into 10 ml
of Columbia liquid broth (Difco, USA) containing 1%
haemin, 1% starch and antibiotics under microaerobic
conditions [25]. The BCFs were prepared by removing
bacteria after centrifugation at 8,000 × g for 15 min fol-
lowed by filtration through 0.22 µm filters (Millipore,
USA) as described earlier [26].
Cytotoxicity assay
Human cervical epithelial cells (HeLa cells) were obtained
from American Type Culture Collection (Manassas, VA).
Cells were grown in Eagle's minimum essential medium
(MEM, Nissui, Japan) supplemented with 10% fetal
bovine serum (Gibco, USA) and 50 µg/ml gentamicin
(Sigma, USA) in 12 well flat bottom plates (Nunc, Den-
mark) to produce semiconfluent monolayer at 37°C in a
humidified atmosphere of 5% CO2. After washing the
cells thrice with serum-free MEM, the cells were incubated
with diluted BCFs (1:10 in MEM) of H. pylori isolates and
the reference H. pylori CCUG 17874. The incubation was
continued for additional 24–48 h under same conditions.
Un-inoculated Columbia broth filtrate (passed through
0.22 µm filter) was used as negative control. The cells were
observed for morphological changes such as vacuoliza-
tion and rounding of cells using inverted microscope
(Nikon, Japan). The viability of HeLa cells was deter-
mined as per trypan blue dye exclusion method.
K+-dependent Adenosine triphosphatase (ATPase) activity
After 24 h incubation with H. pylori BCFs or negative con-
trol, the HeLa Cells were washed thrice with ice-cold 0.15
M NaCl and were scraped in 0.1 M Tris buffer solution
(pH 7.4). The cells suspension was bath-sonicated for 15
sec in ice-cold water. Measurement of K+-dependent
ATPase activity was carried out as per the method of Abdel
Latif etal [27]. Briefly, the cell homogenates were incu-
bated in an assay buffer containing 4.5 mM ATP, 100 mM
NaCl, 20 mM KCl and 0.1 M Tris HCl (pH 7.4) and 0.5
mM ATP for 20 min at 37°C. The reaction was stopped by
adding 100 µl of 50% trichloroacetic acid and the reaction
mixture was centrifuged at 1500 × g for 10 min. Release of
inorganic phosphate (Pi) was assayed by incubating the
supernatants with 2.5 N H2SO4, 5% ammonium molyb-
date and equal amount of reducing agent (0.1% 1-amino
2-naphthol 4-sulphonic acid, 19.5% sodium metabisul-
phite and 0.38% sodium sulphite solution) at room tem-
perature for 10 min [28]. Optical density was read
spectrophotometrically at 660 nm. Potassium dihydrogen
phosphate solution (1.4 mg/ml) in deionized water was
used as standard for measurement of Pi release. To nor-
malize the Pi release, total protein content of HeLa cell
homogenates was estimated by Lowry's method [29]. Spe-
cific ATPase activity was calculated in terms of µmole Pi
liberated per mg protein. All the assays were carried out in
triplicate.
Statistical Analysis
Data were analyzed statistically using Analysis of Variance
(ANOVA) and Chi-square test by Macintosh Statview soft-
ware. The p value less than 0.05 was considered
significant.
Results
This study was done to investigate the degree of gastric
damage in relation to the ability of H. pylori to secrete
cytotoxin in patients with peptic ulcer diseases. All
patients complained of dyspepsia, heartburn and epigas-
tric pain for a period not less than 1 year. The presence of
H. pylori in antral biopsies was established by rapid urease
test, modified Gram's staining of smear and culture of the
biopsies. The gastric and duodenal damage was assessed
by gastro-duodenal endoscopy and histopathology of
Haematoxylin & Eosin stained biopsy samples by light
microscopy. The details of the damage were ascertained at
cellular level by electron microscopy. Cytotoxin produc-
tion was determined in BCFs of H. pylori isolates from
biopsies on HeLa cells. To further investigate the cytotox-
icity, effect of cytotoxin on activity of K+-dependent
ATPase in HeLa cells was studied. A pathological index
was calculated for each patient as follows:
Pathological index = Endoscopy* + Histopathology** +
Cytotoxicity on HeLa cells ***.
*Endoscopy: Normal = 0, Gastritis = 1, Ulcer = 2
**Histopathology: Normal = 0, Chronic superficial gastri-
tis = 1
***Cytotoxicity on HeLa cells: None = 0, Rounding and
vacuolization of HeLa cells = 1.BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/31
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All the patients (10–38 years of age) included in the study,
presented with common dyspeptic symptoms such as
nausea, vomiting and epigastric pain. With the use of
endoscope, signs of hyperemia, hemorrhage, friability,
erosions and erythema were observed in the stomach of
patients having antral gastritis (Group I). Two patients
(Group I) showed no sign of inflammation in stomach or
duodenum after endoscopic examination (Table 1). In
Group II patients, gastric and duodenal ulcers were
observed in the form of white patches in stomach and dif-
ferent parts of the duodenum. Chronic superficial gastritis
was diagnosed in all the patients (Group I and II) and was
recognized histologically by the flattening of microvilli,
presence of inter-epithelial and interstitial polymorphs
infiltration in addition to the lymphocytes and plasma
cells in lamina propria. Epithelial degeneration and regen-
eration were also evident with and without any loss of
glands.
The rapid urease test on gastric biopsies from these
patients was positive indicating the presence of H. pylori.
Light microscopy of biopsy smears, stained with modified
Gram's stain, showed spiral shaped H. pylori in groups
that were unevenly distributed in the biopsies. Smear
examination was taken as positive when H. pylori was
demonstrated in at least one of the impression or crushed
biopsy preparations. Comma and donut forms of H. pylori
were also occasionally seen in primary biopsy smears. The
histopathological findings and colonization of H. pylori
were confirmed further by transmission electron micros-
copy. The electron micrographs of the sections of antral
biopsies of the patients and H. pylori isolates are shown in
figure 1. Electron microscopy confirmed the histopatho-
logical findings at cellular level. Infiltration of inflamma-
tory cells, degeneration of epithelial layer, flattening of
microvilli and H. pylori were clearly visible (Fig. 1b and
1c). The intracellular vacuolization was also visible in H.
pylori infected gastric biopsy (Fig. 1b). The bacteria were
visible in close contact with gastric epithelium and were
sometimes seen residing at the intercellular junctions of
the gastric epithelial cells layer (Fig. 1c). At the site of
adhesion of H. pylori, a cup like invagination was observed
on the surface of gastric epithelial cells (Fig. 1d). Scanning
electron microscopy of all the samples confirmed the spi-
ral shape and smooth, curved surface of bacteria. Repre-
sentative micrographs are shown in figure 1. In addition,
the bacteria were found to possess flagella (figure not
shown). We could not see any of the fine fimbrial or fibril-
lar structures on the surface of any of the H. pylori isolates
by scanning electron microscopy, however, very hazy
structures were visible in transmission electron micro-
graphs of the biopsies at the site of attachment of H. pylori
to the epithelial cell (Fig. 1d).
Once biopsies were cultured under microaerobic condi-
tions, the translucent colonies of bacteria were identified
by testing for the presence of various enzymes unique to
H. pylori. All the isolates were positive for catalase, oxidase
and urease enzymes. Even after further subcultures on
Columbia chocolate agar plates and in liquid broth
medium, H. pylori remained positive for these enzymes
and showed spiral morphology. None of the isolates,
however, showed cocci form of H. pylori in primary as well
as in subsequent cultures.
When BCFs of H. pylori from ulcer patients were added to
the HeLa cells, cytopathic effects were observed marked
with rounding of cells and vacuolization (Fig. 2). Refer-
ence strain H. pylori CCUG 17874 also showed similar
cytopathic effects, i.e., cell rounding and vacuolization.
While all the isolates from ulcer patients were cytopathic,
only 3/7 of H. pylori isolates from Group I patients
showed such effects on HeLa cells. The electron micro-
graphs of gastric biopsies from cytotoxin producing H.
pylori infected patients with peptic ulcer also showed vac-
uolar structures, similar to those observed in vitro in HeLa
cells. These structures were localized on the epithelial sur-
face at the site of attachment of H. pylori (Fig. 1b). No
attempt was made to quantify the degree of cytotoxicity as
seen by microscope except qualitative designation. The
cells remained viable even after 48 h of treatment with
BCFs.
One way to quantify the cytotoxicity of H. pylori was to
measure the activity of K+-dependent ATPase that had
been shown sensitive to H. pylori cytotoxin [30]. The activ-
ity was expressed as µmole of Pi liberated per unit of
protein. BCFs from cytotoxin producing H. pylori CCUG
17874 strain and clinical isolates from Group II (peptic
ulcer) patients caused a significant decrease in K+-depend-
Table 1: Endoscopic and histopathological details of patients.
                           
Endoscopic 
findings                         
Histopathological findings
Group I:
1 Antral gastritis Chronic superficial gastritis
2 Antral gastritis Chronic superficial gastritis
3 Normal Chronic superficial gastritis
4 Normal Chronic superficial gastritis
5 Normal Chronic superficial gastritis
6 Antral gastritis Chronic superficial gastritis
7 Antral gastritis Chronic superficial gastritis
Group II:
1 Duodenal ulcer Chronic superficial gastritis
2 Gastric ulcer Chronic superficial gastritis
3 Duodenal ulcer Chronic superficial gastritis
4 Duodenal ulcer Chronic superficial gastritis
Identification numbers given to the patients are arbitrary numbers.BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/31
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ent ATPase activity of HeLa cells (1.01 µmole/mg protein)
as compared to control, i.e., medium only (2.6 µmole/mg
protein, p < 0.05) (Fig. 3). Heat inactivation (100°C for
15 min) of BCFs of these isolates abolished the
cytotoxicity and the ATPase activity was found compara-
ble to controls. Thus, a heat labile factor was responsible
for cytotoxicity. On the other hand, the mean ATPase
activity of HeLa cells incubated with BCFs of H. pylori iso-
lates (n = 6, ATPase activity was not measured in one of
the four non-cytotoxic isolates from Group I) from Group
I patients did not show any change form the medium con-
trol (Fig. 3). When the group I was divided into two sub-
groups, according to the microscopic cytopathy on HeLa
cells as described above, the same 3/6 cytopathic isolates
decreased ATPase activity of HeLa cells (1.76 µmole/mg
protein, p < 0.05 versus medium); other 3/6 non-cyto-
toxic isolates had no statistically significant effect on
ATPase activity of HeLa cells (3.36 µmole/mg protein). A
correlation was observed between the H. pylori-induced
reduction in HeLa cell ATPase activity and the pathologi-
cal indices calculated for the patients (p = 0.005, Chi-
square and ANOVA). All six patients with pathological
Electron micrographs Figure 1
Electron micrographs: Transmission electron micrographs of antral biopsies of (a) H. pylori negative normal gastric epithelium, 
L-gastric lumen (× 4,400), (b) H. pylori (cytotoxin producing) infected gastritis patient showing vacuolar regions in the epithe-
lium (white arrowhead), L-gastric lumen, (× 7,100), H. pylori (black arrowhead) (c) h-H. pylori on the apical and intercellular 
junctions of epithelial layer (arrowhead), L-gastric lumen, (× 10,400), (d) cup like invaginations on the surface of gastric epithe-
lium at intercellular junction (arrowhead), h-H. pylori, L-gastric lumen (× 21,000).BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/31
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index >2 yielded H. pylori isolates that reduced HeLa cell
ATPase activity to 1.32 µmole/mg protein (2.6 µmole/mg
protein control activity). Chi-square distribution for this
correlation is shown in figure 4.
Discussion
Helicobacter pylori colonizes gastric epithelium and the
presence of H. pylori infection is one of the major determi-
nants in the development of peptic ulcer diseases. The
clinical outcome of H. pylori infection is multifaceted
because only few of the infected individuals develop the
most severe peptic ulcer or gastric carcinoma [31].
Previous studies showed that biologically active cytotoxin
(VacA) is released by certain H. pylori strains that possess
both cagA (cytotoxin-associated gene) and vacA gene
[32,33]. On the basis of cagA gene, attempts have been
made to perform genotyping of H. pylori using cagA (path-
ogenicity island) or iceA (induced by contact with epithe-
lium) gene probes [34,35]. The aim of these studies was to
identify the virulent strains and their correlation with the
disease outcome, but no consensus on the association of
cytotoxin release or expression of cagA gene or cagA anti-
gen with the disease status has been obtained [36,37]. In
fact, extreme diversity was found in the prevalence of
cytotoxin producing H. pylori strains in populations of dif-
ferent geographical regions [38–41].
There have been very few studies available on the charac-
teristics of H. pylori strains from India, where the infection
rate is very high-over 80% [42]. Presence of cagA gene or
antibodies to cagA gene was not found associated with the
outcome of the peptic ulcer disease in Indian patients
[20,21,43,44]. Also, in our previous study we could not
find any association between various biotypes of H. pylori
(on the basis of zymogram and antibiogram) with the dis-
ease outcome [19]. In this context, the variation in the
degree of cytotoxicity or degree of damage induced by
cytotoxic H. pylori strains has also not been studied. Here,
we investigated the relationship between cytotoxin pro-
ducing H. pylori strains and the ensuing gastric mucosal
damage in a small number of patients. Although the role
of host response in mounting an innate and adaptive
immune response cannot be ruled out in the outcome and
severity of disease; we focused only on the virulence
potential of H. pylori. Thus, H. pylori was isolated from
antral biopsies and after characterization, the bacteria was
studied for cytotoxicity in HeLa cells.
Previously it has been reported that the spiral H. pylori
changes its shape to cocci form after isolation and storage
and looses its potent virulence properties [45]. However,
we found that all the isolates, included in this study, were
spiral shaped and were homogenous in their morpholog-
ical and biochemical characteristics as evident from elec-
tron microscopy and the activity of urease, catalse and
oxidase enzymes. The only variation was in their ability to
produce cytotoxin as was evident from the cytopathic
effects on HeLa cells. All the isolates from peptic ulcer
patients produced cytotoxin and only 3/7 isolates from
patients of gastritis group were cytotoxic. Following the
Effect of BCFs of cytotoxic H. pylori on morphology of HeLa  cells. HeLa cells incubated with (a) medium alone (normal  morphology) and (b) BCF of cytotoxic H. pylori Figure 2
Effect of BCFs of cytotoxic H. pylori on morphology of HeLa 
cells. HeLa cells incubated with (a) medium alone (normal 
morphology) and (b) BCF of cytotoxic H. pylori. Rounding 
and vacuolization of cells has been shown (arrowhead). The 
photomicrographs of HeLa cells, shown here were taken 
after 24 h of incubation with BCF or medium from one rep-
resentative experiment.BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/31
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endoscopy, these patients were treated with anti-H. pylori
drug regimen. This is quite possible that if gastritis
patients infected with cytotoxic H. pylori strains were left
untreated, they would have eventually developed peptic
ulcer. However, the patients were not followed further.
To further quantitate the degree of damage induced by H.
pylori cytotoxin, we measured K+-ATPase activity of HeLa
cells. Eukaryotic cells are known to express two types of
ATPase enzyme-V-type (H+-ATPase) and P-type ATPase
(Na+K+-ATPase). H. pylori cytotoxin targets K+-dependent
ATPase and impairs its activity [46]. Earlier, cytotoxin of H
pylori  CCUG 17874 has been shown to decrease the
ATPase activity of MKN28 cells [30]. However, no correla-
tion was made with the clinical outcome. Here, we found
that both cytotoxic H. pylori isolates from Group I (histo-
logical gastritis) and Group II (gastric and duodenal ulcer)
patients inhibited ATPase activity of HeLa cells. In con-
trast, non-cytotoxic isolates from Group I (gastritis)
patients effected no change in ATPase activity of HeLa
cells homogenates. There was a strong correspondence
between reduced ATPase activity of HeLa cells and cyto-
toxin production by H. pylori. This effect is not due to
ammonia released by the action of H. pylori urease, as all
the strains, regardless of source, were positive for urease
activity. However, presence of any other toxic sub-
stance(s) (like proteases) besides cytotoxin in BCFs can-
not be ruled out. Earlier, several clinical and in vitro
studies from isolated parietal cells suggested that H. pylori
infection inhibits acid secretion [47,48] and gastric H+-K+-
ATPase alpha-subunit gene expression [49]. Our data
demonstrate here that the secreted cytotoxin compo-
nent(s) of H. pylori is responsible for the inhibition of
ATPase activity of epithelial cells.
Conclusions
Our study suggests that cytotoxin component of H. pylori
acts on its biochemical target: ATPase in epithelial cells
and inhibits the enzyme activity. Moreover, on the basis
of isolation of cytotoxic H. pylori strains from ulcer
patients, it can be speculated that cytotoxin causes severe
damage to the gastric epithelium. Given the paucity of
Effect of H. pylori BCFs on K+-dependent ATPase activity of HeLa cells Figure 3
Effect of H. pylori BCFs on K+-dependent ATPase activity of HeLa cells. ATPase activity (µmole Pi released/mg protein) of HeLa 
cells was measured after incubating the cells with BCFs of H. pylori isolates. Values are shown as mean (SEM) of three independ-
ent measurements. *p < 0.05 as compared to medium control.BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/31
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information about virulence factors unique to geographi-
cal location outlined by India, this study adds to the avail-
able knowledge base about H. pylori. In developing world
where infections with antibiotic-resistant H. pylori is very
common, the application of therapeutic or prophylactic
vaccines can be useful in preventing H. pylori infection
[50]. So far, vaccination studies have not been completely
successful, the cytotoxin released by H. pylori is still at the
first place on the list of many putative virulence factors
and a potent candidate for vaccine production. However,
more studies on the activity of cytotoxin at molecular
level, host response in an animal model should provide
the basis for the design of an effective vaccine.
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